Originally published In Press as doi:10.1074/jbc.M109045200 on December 20, 2001
J. Biol. Chem., Vol. 277, Issue 9, 7108-7117, March 1, 2002
Structural Plasticity in Influenza Virus Protein NS2 (NEP)*
Barbara S.
Lommer and
Ming
Luo
From the Department of Microbiology, University of Alabama at
Birmingham, Birmingham, Alabama 35294-4400
Received for publication, September 19, 2001, and in revised form, December 18, 2001
 |
ABSTRACT |
The cellular nuclear transport machinery relies
on the assembly of specialized transport complexes between soluble
transport receptors, transport substrates, and additional accessory
proteins. This study focuses on the structural characteristics of
influenza virus protein NS2 (NEP), which interacts with the nuclear
export machinery during viral replication, and has been proposed to act as an adapter molecule between the nuclear export machinery and the
viral ribonucleoprotein complex. For this purpose, we have purified
recombinant NS2 under nondenaturing conditions, and have investigated
its structure and aggregation state using optical spectroscopy,
differential scanning calorimetry, as well as hydrodynamic techniques.
Our results indicate that isolated NS2 exists as a monomer in solution,
and adopts a compact, but very flexible conformation, which shows
characteristics of the molten globule state under near physiological
conditions. Proteolytic sensitivity suggests that, despite its overall
plasticity, the structure of NS2 is heterogeneous. While the C terminus
of the protein adopts a relatively rigid conformation, its N terminus,
which is recognized by the nuclear export machinery, exists in a highly
mobile and exposed state. It is proposed that the flexibility observed
in the nuclear export domain of NS2 is an important element in the
recognition of substrate proteins by the nuclear export machinery.
 |
INTRODUCTION |
Active transport of macromolecules across the nuclear membrane is
an important mechanism in the regulation of gene transcription and
translation. Signal-mediated transport is typically initiated by
soluble transport receptors that recognize cis-acting nuclear transport
signals in their substrates and target their cargo to the nuclear pore
complex. Translocation through the nuclear pore, release of substrate
after transport, and directionality of the transport process are
thought to be achieved mainly through action of the GTPase Ran and its
regulatory factors (1-3).
Influenza virus, like many viruses that replicate in the nucleus, takes
advantage of these cellular pathways to translocate its genome,
mRNAs, and proteins across the nuclear membrane (4, 5). Three
influenza virus proteins in particular have been found to interact with
the nuclear transport machinery: nucleoprotein (NP),1 matrix protein (M1),
and the nonstructural protein 2 (NS2, also called NEP).
NP encapsidates the viral genomic RNA (6, 7), is able to shuttle
between the nucleus and the cytoplasm (8), and is thought to catalyze
the import of the viral ribonucleoprotein complexes (vRNPs) into the
nucleus at early times after infection (9-11). In addition, NP
interacts with the nuclear export receptor Crm1 in vitro and
has been proposed to achieve the nuclear export of progeny vRNPs during
virion assembly (12).
M1 is also transported into the nucleus (13) where it associates with
the vRNPs (14). While it has been shown to be essential for vRNP export
(14, 15), its role in this process is not clearly defined. M1 may
escort the progeny vRNPs out of the nucleus (14), release the vRNPs
from the nuclear matrix (16, 17), and/or prevent the reimport of the
vRNPs after translocation (8).
The small protein NS2 is the latest influenza protein for which an
interaction with the nuclear export machinery has been identified. NS2s
of both type A and type B influenza viruses contain a HIV-1 Rev-like
nuclear export signal (NES) at their N terminus that has been shown to
interact with cellular nucleoporins in a yeast two-hybrid system, and
that can mediate the nuclear export of heterologous proteins (18, 19).
In addition, full-length NS2, as well as peptides corresponding to the
NS2 NES, can functionally replace the HIV-1 Rev effector domain
(18-20), which promotes the nuclear export of unspliced HIV-1 RNA
(21). As in case of Rev, the integrity of the NS2 NES is essential for
nuclear export of the protein, but not for interaction of NS2 with the
soluble export receptor Crm1 (19, 22, 23). The functional importance of the recognition of NS2 by the nuclear export machinery is currently the
subject of intense discussion. NS2 was found to be essential for export
of progeny vRNPs in some studies (18, 23), and was also found
indispensable for the generation of functional virus-like
particles in a plasmid transfection system (19, 24, 25). In
addition, the C terminus of NS2 has been shown to interact with M1 both
in vivo and in vitro (26, 27). Based on these observations, it has been proposed that NS2 mediates the export of
vRNPs by acting as an adapter protein between the nuclear export machinery and the M1·vRNP complex (18, 19, 23).
Rev-like NESs, as found in NS2, are thought to be crucial for
stabilization of the ternary RanGTP·NES·Crm1 complex that is responsible for export of transport substrates by this
Crm1-dependent pathway (22, 28). While the interactions
involved in signal-mediated nuclear import have been the subject of
intense study in recent years, the molecular processes involved in the
assembly of this ternary export complex, as well as in the specific
recognition of the export substrates by the nuclear transport
machinery, remain ill defined. Structural studies of the nuclear export
complex itself and of its principal constituents in solution will
therefore provide valuable insights into the molecular mechanisms
involved in the nuclear export process.
This study focuses on the structural characteristics of NS2 that allow
it to interact with its ligands. Our results indicate that the nuclear
export domain of isolated NS2 exists in an exposed and highly flexible
conformation in solution. The C terminus of the protein, in contrary,
adopts a relatively rigid structure, but lacks a tightly packed
hydrophobic core under near physiological conditions. It is proposed
that the high degree of flexibility observed in the nuclear export
domain of NS2 is associated with the recognition of substrate proteins
by the nuclear export machinery.
 |
EXPERIMENTAL PROCEDURES |
Expression and Purification of Recombinant NS2--
The NS2
cDNA of influenza strain InfA/PR/8/34 was subcloned into a pET21b
expression vector (Novagen). This construct was designed to allow
expression of a full-length version of NS2 that carried no tags or
additional residues. The correct NS2 sequence in the resulting
pET21bNS2 plasmid was confirmed by DNA sequencing.
For protein expression, pET21bNS2 was transformed into
Escherichia coli strain BL21(DE3) (Novagen), and the cells
were grown to an A600 of 0.8-1.0 at 37 °C in
Luria-Bertani medium containing 200 µg/ml ampicillin. At this point,
protein expression was induced by addition of 0.5 mM
isopropyl-
-D-thiogalactopyranoside. After incubation for
20 h at 18 °C, the cells were harvested by centrifugation and
resuspended in lysis buffer (50 mM NaCl, 20 mM
Tris, 1 mM EDTA, pH 8.5). The cells were broken by
sonication using a 550 Sonic Dismembrator (Fisher Scientific), and
insoluble material was removed by centrifugation for 20 min at 10,000 rpm in a JA-20 rotor (Beckman).
NS2 was captured by gel filtration on a Sephacryl-S300 26/60 HR column
(Amersham Biosciences, Inc.) from the soluble fraction of the cell
lysate. The separation was performed using elution buffer A (150 mM NaCl, 20 mM Tris, 1 mM EDTA, pH
8.5), and NS2 was found to elute as a single peak at about 239 ml as
confirmed by SDS-PAGE and Coomassie Brilliant Blue staining. The NS2
containing fractions were pooled and concentrated by ultrafiltration
through a YM3 filter (Amicon). Further purification of NS2 was
accomplished by gel filtration on a Sephadex-75 16/60 HR column
(Amersham Biosciences, Inc.) using elution buffer B (150 mM
NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.5). Again,
NS2 was found to form a single peak that eluted at about 78 ml, and the
appropriate fractions were pooled and the buffer exchanged to 20 mM HEPES, 1 mM EDTA, pH 7.0, by ultrafiltration and dilution. Subsequently, NS2 was passed through a Hitrap SP column
(Amersham Biosciences, Inc.), and bound proteins were eluted with 1 M NaCl, 20 mM HEPES, 1 mM EDTA, pH
7.0. While contaminant proteins were bound to the column, NS2 remained
in the flow through.
Protein quantitation was performed by absorbance at 280 nm, using an
extinction coefficient of 12,660 M
1
cm
1 calculated from the amino acid composition of the
protein (29). Following purification, NS2 was dialyzed against protein
storage buffer (150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.5), concentrated to about 1 mg/ml by
ultrafiltration, and transferred to 4 °C. Further buffer exchange
and protein concentration was accomplished by dialysis and
ultrafiltration as necessary.
Purity and Identity of Bacterially Expressed NS2--
Denaturing
isoelectric focusing (IEF) of purified NS2 was performed using the
PhastSystemTM automated electrophoresis system (Amersham
Biosciences, Inc.). IEF was carried out utilizing a dry IEF
PhastgelTM rehydrated with 6.25% PharmalyteTM
4-6.5 (Amersham Biosciences, Inc.) in 8 M urea, and
protein detection was accomplished by staining with Coomassie Brilliant
Blue. Before separation, NS2 samples were incubated for 2.5 h in
protein storage buffer + 8 M urea. To assure completion of
the focusing process, all samples were applied at both the cationic and
the anionic end of the gel.
Matrix-assisted laser desorption ionization-mass spectrometry of
purified NS2 was performed at the UAB Mass Spectrometry Core Facility
on a Voyager Elite matrix-assisted laser desorption ionization-time of
flight instrument (PerSeptive Biosystems) with delayed extraction. Internal calibration with reference proteins thioredoxin (11674.5 Da)
and apomyoglobin (16952.5 Da) was used for molecular mass determination. For N-terminal sequencing, NS2 was electroblotted onto a polyvinylidiene difluoride membrane (Bio-Rad) and Automatic Edman degradation (6 cycles) of the NS2 band was carried out at the UAB
Protein Sequencing Core Facility using a Model PI 2090E (Beckman) sequencer.
Near ultraviolet absorption spectroscopy of NS2 was performed on 0.5 mg/ml NS2 in protein storage buffer using a 1-cm cell. Experiments were
carried out at 25 °C utilizing a Beckman DU 650 spectrophotometer,
and the NS2 UV absorbance spectra were corrected by subtraction of the
buffer baseline.
The ability of recombinant NS2 to associate with influenza virus matrix
protein M1 of both viral and bacterial origin was assayed by
far-Western blot similar as described in Ref. 26. Briefly, purified
InfA/PR/8/34 virus was prepared as described in Ref. 30. Recombinant,
hexahistidine-tagged InfA/PR/8/34 M1 protein was produced in E. coli using the pET21b expression vector. Protein expression was
accomplished by growing BL21(DE3)pET21b M1 cells for 16 h at
37 °C in the absence of
isopropyl-
-D-thiogalactopyranoside. Subsequently, the
cells were harvested, resuspended in 0.5 M NaCl, 20 mM Tris, 5 mM imidazole, pH 7.9, and lysed by
sonication as described above. Purification of M1 was achieved by
incubation of the cell lysate supernatant with chelating Sepharose
(Amersham Bioscience Inc.), and elution was performed according to the
manufacturers instructions. Detection of M1 bound NS2 was accomplished
utilizing monospecific, mouse anti-NS2 antibodies that had been raised
against a hexahistidine-tagged, affinity-purified version of
bacterially expressed
NS2.2
Analytical Ultracentrifugation--
Sedimentation equilibrium
ultracentrifugation of NS2 was performed at the UAB Analytical
Ultracentrifuge Analysis Facility on a Beckman XL-A Analytical
Ultracentrifuge using an AN-60 Ti rotor (Beckman). NS2 samples at a
concentration of 0.3, 0.7, 1.0, and 1.3 mg/ml NS2 in protein storage
buffer were stored for 1 week at 4 °C before analysis. Subsequently,
double sector cells were loaded with 120 µl of protein sample or
protein storage buffer, respectively, and sedimentation equilibrium
data were obtained at 29,000, 34,000, and 48,000 rpm at 20 °C.
Protein detection was carried out by absorbance at 280 nm after
equilibrium was reached. The equilibrium data was edited by deletion of
absorbance changes at the protein and reference meniscus interface. In
addition, absorbance values greater than 1.5 at the steepest part of
each absorbance versus radial position exponential were
deleted to ensure that only data obeying Beer's law were used in the
nonlinear regression analysis. The partial specific volume of NS2 was
calculated as 0.7367 cm3/g from its amino acid sequence.
For modeling sedimentation equilibrium data, the data were merged, and
a global nonlinear least squares analysis of the edited data sets was
performed using the software packages XL-A v4.0 (Beckman) and Origin
v4.1 (Microcal). Fitting the experimental data to both a single ideal
species model and to a monomer-dimer self-association model was
attempted. In addition, whole cell apparent weight average molecular
masses were determined from each individual data set as well.
Analytical Gel Filtration Chromatography--
Analytical gel
filtration of purified NS2 was carried out on a Sephadex-75 16/60 HR
gel filtration column (Amersham Biosciences, Inc.). NS2 at a
concentration of 0.5 mg/ml in protein storage buffer was loaded onto
the column, and the protein was eluted with the same buffer. If the gel
permeation properties of NS2 were determined under denaturing
conditions, NS2 was incubated for 4.5 h in protein storage buffer + 8 M urea prior to elution with this buffer. Protein
elution was followed by absorption at 260 and 280 nm, and the elution
profiles were corrected by subtraction of the appropriate buffer
baselines. Purity and homogeneity of the observed NS2 peaks were
confirmed by SDS-PAGE and by observation of the
A280/A260 absorbance
ratio over the NS2 peak as described in Ref. 31. For determination of
the Stokes radius, the column was calibrated using the Amersham
Biosciences Inc. gel filtration low molecular weight calibration kit.
Blue dextran 2000 (Amersham Biosciences, Inc.) was used to determine
the void volume of the gel filtration column both in the presence and
absence of 8 M urea. The frictional ratio
f/f0 of NS2 was calculated according to Ref. 32 using the following equation,
|
(Eq. 1)
|
M is the molecular weight,
designates the Stokes
radius,
is the partial specific volume, and N is
Avogadro's number.
Circular Dichroism (CD) Spectroscopy--
CD spectroscopy of NS2
was carried out on an Aviv model 62DS CD spectrometer equipped with a
thermostated cell holder. Far-UV CD spectra of NS2 were recorded at
25 °C on 0.8 mg/ml NS2 in 20 mM borate/boric acid, pH
7.5, using a 0.01-mm cell. The data were averaged over 2 repeat scans
and corrected by subtraction of the buffer baseline. The secondary
structure content of NS2 was estimated by analysis of the normalized
NS2 spectrum (188-240 nm) as a combination of 3 reference spectra
(
-helix,
-sheet, random coil) using the program PROSEC (Aviv
Associates). To verify the results, a synthetic spectrum with the same
structural components as determined for NS2 was created using the
program BLEND (Aviv Associates) and compared with the original NS2
spectrum. Near-UV CD spectroscopy of NS2 was carried out at 25 °C
using a 1-cm cell. Data was acquired on 1.0 mg/ml NS2 in protein
storage buffer, or on 1.0 mg/ml NS2 in protein storage buffer
containing 6 M guanidinium chloride (GdmCl). Each data set
was averaged over 5 scans, and the spectra were corrected by
subtraction of the appropriate buffer baselines.
Fourier Transform-Infrared (FT-IR) Spectroscopy--
Infrared
absorption spectra of 10.0 mg/ml NS2 in protein storage buffer were
acquired at room temperature (23.1 °C) using a PROTA FT-IR
instrument (Bomen). The data were averaged over 400 scans, corrected by
subtraction of the air, buffer, and cell baselines, and normalized. The
secondary structure content of NS2 was determined by analysis of the
NS2 amide I band as a linear combination of the spectra of 32 reference
proteins of known x-ray crystallographic structure using the PROTA
software (Bomen).
Fluorescence Spectroscopy--
Fluorescence spectroscopy of NS2
was performed on a SLM 8000C spectrofluorometer equipped with a
thermostated cell holder. All experiments were carried out at 25 °C
using a 1-cm cell, and samples were stirred during data acquisition to
minimize artifacts due to photochemical degradation. After excitation
at 290 nm, protein fluorescence emission spectra were collected on
0.026 mg/ml NS2 (A280 = 0.05) in protein storage
buffer, or in protein storage buffer containing 6 M GdmCl,
respectively. Due to rapid photodegradation of NS2, fluorescence
quenching experiments were carried out using individual NS2 samples
containing 0-600 mM acrylamide. 4,4-Dianilino-1,1-binaphthyl-5,5-disulphonic acid (ANS) binding studies
were performed at an excitation wavelength of 370 nm using a molar
NS2/ANS ratio of 1:3. Spectra were corrected for buffer fluorescence
and for variation of light source intensity and detector response
versus wavelength (33). Analysis of NS2 quenching data was
carried out according to Ref. 34 using the following modified form of
the Stern-Volmer equation (35),
|
(Eq. 2)
|
where [Q] designates the concentration of the
quenching agent and F0 and F are the
fluorescence intensities at wavelength
in the absence and presence
of the quencher, respectively. While V characterizes the
static component of the quenching process, KSV
describes its collisional component. The effective quenching constant
KSV(eff) was obtained from the initial slope of
the Stern-Volmer plot and normalized for increase of the solution
viscosity due to GdmCl as described in Ref. 34.
Conformational Stability of NS2--
Thermal denaturation of NS2
was monitored by CD spectroscopy at 220 nm. 0.026 mg/ml NS2 in 20 mM borate/boric acid, pH 7.5, in a 1-cm cell was heated
under stirring from 10 to 90 °C using increments of 0.5 °C. The
temperature inside the sample cell was monitored by directly inserting
a thermistor into the cell. To assure reversibility of the denaturation
process, the sample was allowed to cool to room temperature after the
experiment was complete, and the far-UV CD spectrum of the renatured
protein was compared with the spectrum of NS2 collected before the
heating experiment.
Differential scanning calorimetry of NS2 was carried out on Model 6100 Nano II Differential Scanning calorimeter (Calorimetry Sciences Corp.)
equipped with a capillary cell. Freshly purified NS2 at a concentration
of 0.4, 0.7, and 1.0 mg/ml in 20 mM borate/boric acid, pH
7.5, and/or in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.5, was heated from 5-100 or 5-80 °C,
respectively, using heating rates between 0.5 and 2 °C/min. The
denaturation data was corrected by subtraction of the buffer baseline
and converted to partial molar heat capacity using the program CpCalc
(Calorimetry Sciences Corp.). Reversibility of the denaturation process
was confirmed by subsequent cooling of the sample to 5 °C, followed
by additional rounds of heating. The partial heat capacities of the
fully unfolded polypeptide were estimated according to Refs. 36 and
37.
Solvent-induced unfolding of NS2 was carried out by addition of GdmCl
and was followed by fluorescence spectroscopy and far-UV CD
spectroscopy. When unfolding was analyzed by fluorescence spectroscopy, 0.026 mg/ml NS2 was incubated in protein storage buffer containing 0-6
M GdmCl for 5 min at room temperature. Subsequently,
fluorescence spectra were collected as described above using an
excitation wavelength of 273 nm, as at this wavelength the folded and
unfolded forms of NS2 showed no difference in UV absorbance. When NS2
unfolding was followed by far-UV CD spectroscopy, 0.26 mg/ml NS2 was
incubated in 150 mM NaCl, 20 mM borate/boric
acid, 0-6 M GdmCl, pH 7.5, for the same amount of
time. CD spectra were collected at 25 °C using a 2-mm cell, and the
data was corrected as described above. Completeness of the unfolding
process was assured by examination of fluorescence and CD data of NS2
samples that had been exposed to GdmCl for different periods of time
(5-90 min). Reversibility of the unfolding process was tested by
examination of CD or fluorescence spectra of NS2 samples that had been
unfolded by exposure to 6 M GdmCl and had subsequently been
refolded by 1:10 (v/v) dilution in GdmCl-free buffer. The
solvent-induced unfolding data of NS2 was analyzed assuming a two-state
mechanism of unfolding. The equilibrium constant K and the
Gibbs free energy change
G of the unfolding reaction were
calculated according to the following.
|
(Eq. 3)
|
|
(Eq. 4)
|
Here fF and fU are the
fractions of folded and unfolded protein, respectively. y is
the observed value at any point during the denaturation process.
yF and yU are the values of
y characteristic of the folded and unfolded state of NS2 and
were obtained by extrapolation of the pre- and post-transition regions
of the NS2 denaturation curves. R and T denote
the gas constant and the absolute temperature, respectively.
G(H2O), the conformational stability of the
protein in the absence of denaturant, was obtained by least squares
analysis of the linear region of the
G versus
[GdmCl] plot as described in Ref. 38.
Protease Mapping of NS2--
Limited proteolysis experiments of
NS2 were performed at 37 °C using immobilized trypsin (Sigma) and
immobilized Staphylococcus aureus V8 protease (Pierce).
Trypsin digestions were carried out for 0.5-16 h using 0.01-0.4
units of trypsin/mg of NS2 in 150 mM NaCl, 50 mM HEPES, pH 8.0. V8 protease digestions were performed for
1-24 h using 0.5-4 units of V8 protease/mg of NS2 in 150 mM NaCl, 20 mM HEPES, pH 7.8. Reactions were
stopped by filtration through 0.2-µm Millipore Ultrafree centrifugal
filtration units and analyzed by 13.5% SDS-PAGE and staining with
Coomassie Brilliant Blue. N terminus sequencing of the digestion
products was carried out as described for full-length NS2. A C-terminal
hexahistidine-tagged version of NS22 that yielded the same
digestion products as untagged NS2 was used to determine whether the
identified NS2 fragments retained the same C terminus as the undigested
protein. For this purpose, full-length, hexahistidine-tagged NS2 and
its digestion fragments were blotted onto nitrocellulose, and retention
of the C-terminal hexahistidine tag was analyzed by Western blot using
monoclonal anti-His antibodies (Qiagen) and the monoclonal anti-NS2
antibodies described above.
 |
RESULTS |
Isolated, Recombinant NS2 is Pure and Active--
InfA/PR/8/34 NS2
protein was expressed in E. coli and purified from the
soluble fraction of the bacterial lysate by a combination of size
exclusion and cation exchange chromatography. The purity, identity, and
homogeneity of isolated NS2 were analyzed using a number of different
techniques. SDS-PAGE produced a single band that migrated with an
apparent molecular weight of about 11,000, as observed for the
viral protein (39). If the NS2 preparation was subjected to denaturing
IEF, only one band was observed as well. Matrix-assisted laser
desorption ionization-time of flight mass spectrometry revealed a
single species of 14,382.8, which is consistent with the molecular
weight of NS2 calculated from the amino acid sequence of the native
protein (14,380.3) (40). N-terminal sequencing of the purified protein
yielded the sequence MDPNT as expected for InfA/PR/8/34 NS2. The
near-UV absorption spectrum of NS2 showed only marginal absorbance
above 300 nm, confirming that the NS2 preparation was free of
aggregates. The A260 nm/A280
nm ratio of the protein preparation was 0.69, indicating that it
contained less than 1% nucleic acids (41, 42). Furthermore, recombinant NS2 was found to associate with influenza virus matrix protein M1 in a far Western blot assay that was carried out as described in Refs. 26 and 27 (data not shown). Based on these observations, isolated, recombinant NS2 was judged chemically pure and
active with respect to binding to influenza virus matrix protein
M1.
NS2 Exists as a Compact Monomer in Solution--
The aggregation
state and gross conformation of isolated NS2 were probed by a
combination of hydrodynamic techniques. Sedimentation equilibrium
ultracentrifugation allows the determination of the molecular weight of
intact proteins, independent of frictional effects due to molecule
shape or hydration (43). NS2 was subjected to ultracentrifugation at
protein concentrations between 0.3 and 1.4 mg/ml using a range of
different centrifugation speeds (Fig. 1A). The average apparent
molecular mass of NS2 was determined as 14,153 Da (with 95% confidence
limits of 14,126 Da and 14,179 Da) by global analysis of all data sets
assuming a single, non-interacting species. Upon separate examination
of the individual data sets, no significant change of the apparent
molecular mass of NS2 was observed with increased protein
concentration, nor was significant non-ideality detected with increased
rotor speed.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
The aggregation state and shape of isolated
NS2. A, analysis of NS2 by sedimentation equilibrium
ultracentrifugation. NS2 at a concentration of 0.4-1.3 mg/ml in
protein storage buffer (150 mM NaCl, 20 mM
HEPES, 1 mM EDTA, pH 7.5) was stored at 4 °C for 1 week,
and then analyzed at multiple centrifugation speeds. All data was
fitted globally to a single, non-interacting species model. The
sedimentation equilibrium profile shown was obtained using a protein
concentration of 0.7 mg/ml and a centrifugation speed of 29,000 rpm,
and is representative of all data sets. The solid line
represents the global fit. B, analysis of NS2 by
analytical gel filtration. Estimation of the Stokes radius of NS2 was
carried out by gel filtration using a protein concentration of 0.5 mg/ml in protein storage buffer or protein storage buffer + 8 M urea. The protein standards used
were: 1) ribonuclease A (13.7 kDa); 2)
chymotrypsinogen A (25.0 kDa); 3) ovalbumin (43.0 kDa); and
4) albumin (67.0 kDa). The Kav value
represents the normalized elution behavior of the solutes.
|
|
In contrast to sedimentation equilibrium ultracentrifugation,
analytical gel filtration is sensitive to the Stokes radius of a
particle, rather than to its molecular weight (32). This parameter can
be used to obtain the frictional ratio of a protein, which is a measure
of its departure from a smooth, unhydrated sphere of equal molecular
weight. When NS2 was analyzed by analytical gel filtration under near
physiological conditions, it was found to elute in a single,
homogeneous peak. Comparison of the elution volume of NS2 with the
elution volumes of several globular reference proteins estimated the
Stokes radius of NS2 as 16.6 Å (Fig. 1B). This value was
found to correspond to a molecular weight of about 15,000, consistent
with the molecular weight of NS2 determined by analytical
ultracentrifugation. The frictional ratio of NS2 was calculated as
1.03, a ratio typical of compact proteins (32). In the presence of 8 M urea, a dramatic shift in the elution volume of NS2 was
observed, which eluted with a Stokes radius of 35.6 Å and a frictional
ratio of 2.21. In contrast, the void volume of the gel filtration
column did not change significantly (44.55 versus 43.47 ml
in the absence of urea), indicating that the permeation properties of
the gel filtration matrix did not change under these conditions. These
results indicate that isolated NS2 exists as a globular,
non-interacting monomer under near physiological conditions, and adopts
an extended conformation only after solvent-induced denaturation.
Nonetheless, in NS2 preparations that had been stored for extended
periods of time (several weeks), a small amount (
10% of total
protein) of NS2 dimer could be found by SDS-PAGE and gel filtration
similar as reported by Ward et al. (27) for a glutathione S-transferase fusion form of NS2. This interaction was not
found in fresh samples (1-2 weeks old) and usually coincides with the appearance of small amounts of irreversibly precipitated protein.
NS2 Adopts a Folded, but Highly Flexible Conformation--
The
structure and dynamics of NS2 in solution were studied using different
methods of optical spectroscopy. The far-UV CD spectrum of a protein is
dominated by the contribution of its peptide bonds, and can be
described as a superposition of spectra distinctive of the different
types of regular secondary structure present in the polypeptide (44).
Purified NS2 was probed by far-UV CD spectroscopy under a variety of
buffer conditions to obtain an estimate of its secondary structure
composition. At near physiological conditions, the CD spectrum observed
for NS2 displays two minima centered at 208 and 222 nm and is typical of a folded protein containing a considerable amount of
-helical structure (45) (Fig. 2A). No
significant changes of the spectrum were observed if the pH of the
solution was varied between 6.0 and 11.0, whereas at pH values close to
the calculated isoelectric point of NS2 (pI 5.1) reversible
precipitation of the protein occurred. Likewise, variation of the ionic
strength of the solution between 0 and 2 M NaCl did not
lead to significant changes in the CD spectrum. Quantitative
determination of the secondary structure content of NS2 was carried out
as described in Ref. 45 using CD data between 188 and 240 nm recorded
at 25 °C. The secondary structure of NS2 was found to consist of
57.8%
-helix, 15.9%
-sheet, and 26.3% reverse turn or random
coil. Furthermore, the secondary structure of NS2 was probed by FT-IR
spectroscopy, a technique which relies on the amide bands observed in
the infrared absorption spectrum of polypeptides. These bands are
formed by overlapping absorption bands corresponding to the different
types of secondary structure and can be analyzed as a combination of the spectra of reference proteins of known crystallographic structure (46, 47). The infrared absorption spectrum of NS2 displays a strong
amide I band centered at 1653 cm
1, as expected for a
predominantly
-helical conformation (46) (Fig. 2B). From
this data, the secondary structure elements of NS2 were estimated as
42.6%
-helix, 17.2%
-sheet, 17.0% reverse turns, and 24.7%
random coil using the PROTA procedure (Bomen). These results indicate
that isolated NS2 contains a significant amount of secondary structure
in solution. The agreement between the estimates of the secondary
structure composition of NS2 obtained by CD and FT-IR spectroscopy can
be considered satisfactory in light of the differences between the
basic spectra libraries utilized by both methods.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Secondary structure content of
NS2. A, far-UV circular dichroism spectra of NS2.
Solid line, NS2 in 150 mM NaCl, 20 mM borate/boric acid, pH 7.5, 25 °C. +++, NS2 in 150 mM NaCl, 20 mM borate/boric acid, pH 7.5, 80 °C. , NS2 in 150 mM NaCl, 20 mM
borate/boric acid, 6 M guanidinium chloride, pH 7.5, 25 °C. [ ]MRW, mean molar ellipticity. B,
infrared absorbance spectrum of NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.5, recorded at room
temperature (23.1 °C).
|
|
Aromatic groups that are immobilized in an asymmetric environment in
well structured proteins produce highly characteristic bands in the
near-UV region of the CD spectrum that result from the interaction of
the aromatic side chains with neighboring groups (48). The near-UV CD
spectrum of NS2, which contains two tryptophans and one tyrosine, but
no intrinsically active disulfide bonds, was recorded to probe the
stability of its tertiary structure. Interestingly, the near-UV CD
spectrum obtained at near physiological buffer conditions was virtually
zero, and resembled the spectrum of the protein in the presence of 6 M GdmCl (Fig. 3). These
observations suggest that under native buffer conditions, the aromatic
groups of NS2 are able to rotate freely and undergo no strong
interactions with other groups within NS2 (48). To further analyze the
tightness and stability of the tertiary structure of NS2, the protein
was probed by tryptophan fluorescence spectroscopy. The wavelength at
which the maximum fluorescence emission of tryptophan is observed depends on the polarity of its immediate environment, and, in native
proteins, is usually significantly blue-shifted compared with the
emission maximum of free tryptophan in solution (44). Furthermore, the
efficiency and pattern with which the tryptophan fluorescence of a
protein is quenched by the collisional quencher acrylamide provides a
measure of the dynamics of the protein, and of the exposure its
tryptophan residues to the solvent (34, 50). When the tryptophan
fluorescence emission spectrum of NS2 was recorded under near
physiological buffer conditions, its emission maximum was found to
exhibit only a small blue-shift compared with its emission maximum
under denaturing conditions. Addition of acrylamide led to rapid
quenching of the tryptophan fluorescence, comparable to tryptophan
quenching under denaturing conditions (Table
I). The Stern-Volmer plot of the
quenching reaction showed upward curvature, indicating that both
tryptophan residues of NS2 were nearly equally assessable to the
solvent (Fig. 4) (34). In conjunction
with the observations made by near-UV CD spectroscopy, these results
suggest a dynamic, loosely packed tertiary structure in the vicinity of
the aromatic residues of NS2.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Near-UV circular dichroism spectra of
NS2. Spectra were recorded at 25 °C using a protein
concentration of 1.0 mg/ml NS2 in a 1-cm cell. , NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH
7.5. , NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, 6 M guanidinium chloride, pH
7.5.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Acrylamide quenching of the intrinsic
fluorescence of NS2. Quenching experiments were carried out at
25 °C using an excitation wavelength of 290 nm. , NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH
7.5. , NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, 6 M guanidinium chloride, pH
7.5.
|
|
To determine whether the flexibility observed by near-UV CD and
tryptophan fluorescence spectroscopy is due to local disorder in the
proximity of the aromatic groups, or if it reflects a more general
property of the NS2 structure, binding experiments with the hydrophobic
dye ANS were carried out. This probe strongly associates with
hydrophobic clusters in compact proteins that possess pronounced
secondary structure but lack a tightly packed tertiary structure. In
contrast, coil-like proteins,
-helical and
-sheet structural
homopolypeptides as well as proteins containing a rigid hydrophobic
core show only very little affinity for ANS (51). In the presence of
NS2, the fluorescence intensity of ANS was found to increase 7-fold,
and its emission maximum was significantly blue-shifted compared with
the emission maximum of ANS in the absence of the protein, pointing to
a strong interaction of the probe with NS2 (Table I) (51). In contrast,
if NS2 was added to ANS in the presence of 6 M GdmCl, no
such interaction was observed. These results suggest that NS2 possesses
a loosely packed hydrophobic core that is accessible to the solvent, as expected for a folded protein with a dynamic tertiary structure.
Denaturation by heat or chemical denaturants can also be used to probe
the structure and conformation of proteins in solution. The
temperature-induced denaturation of small globular proteins is commonly
a two-state transition, even so the temperature-denatured state of
these proteins is often compact, and typically retains a substantial
amount of secondary structure (52). When thermal unfolding of NS2 was
followed by far-UV CD spectroscopy, a broad, nonlinear transition was
observed that was highly reversible. The end point of this transition
was reached at ~80 °C, at which point NS2 was found to retain
about 50% of its secondary structure (Figs. 2A and
5A). To further explore the
character of this transition, the enthalpy change associated with
temperature-induced denaturation of NS2 was measured directly using
differential scanning calorimetry. Temperature-induced denaturation of
small, native proteins is typically accompanied by a single, distinct
heat absorption peak of several J × K
1 × g
1 (53). Surprisingly, the partial specific heat capacity
function of NS2 was found to increase monotonously with
increasing temperature, and was devoid of any excess heat absorption
(Fig. 5B). At 25 °C, the partial specific heat capacity
of NS2 of 1.65 J × K
1 × g
1 was
significantly lower than the partial specific heat capacity expected
for the fully unfolded protein (2.06 J × K
1 × g
1), and was in a range typically observed for
native proteins of similar size (37). At 75 °C, the partial specific
heat capacity of NS2 (2.06 J × K
1 × g
1) approached the value expected for the fully unfolded
polypeptide chain (2.23 J × K
1 ×g
1),
but did not quite reach it. These results indicate that NS2 assumes a
compact conformation at room temperature, and partially unfolds upon
heating to 80 °C. As the increase in heat capacity upon protein
denaturation is believed to be due to the exposure of nonpolar groups
to the solvent (54), the lack of excess heat absorption upon
denaturation of NS2 indicates that isolated NS2 possesses an only
loosely packed hydrophobic core.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Thermal denaturation of NS2.
A, thermal denaturation of NS2 as monitored by far-UV
circular dichroism spectroscopy at 220 nm. 0.026 mg/ml NS2 in 20 mM borate/boric acid, pH 7.5, was heated under stirring
from 10 to 90 °C using increments of 0.5 °C/min.
[ ]MRW, mean molar ellipticity. B, thermal
denaturation of NS2 as monitored by differential scanning calorimetry.
1.0 mg/ml NS2 in 150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.5, was heated from 5 to 80 °C using a scan
rate of 1 °C/min.
|
|
In contrast to temperature-induced denaturation, solvent-induced
unfolding of native proteins by high concentrations of denaturants is
accompanied not only by the loss of the tertiary structure of the
protein, but leads to almost complete unfolding and loss of the compact
protein conformation (52). When the unfolding of NS2 by GdmCl was
followed by far-UV CD and tryptophan fluorescence spectroscopy, two
nearly identical, highly cooperative unfolding curves were obtained
(Fig. 6). As expected, these results
indicate that the unfolding of NS2 is dominated by the unfolding of its secondary structure. Assuming a two-state mechanism of unfolding, the
conformational stability
G(H20) of NS2 was
estimated as about 6 kcal/mol as described in Ref. 38 (Table
II). This value is at the lower end of
the range of stabilities commonly observed for solvent-induced
unfolding of globular proteins (
G(H20)
5-10 kcal/mol) (55). The m value, which represents the
dependence of the free energy of unfolding on the denaturant
concentration, was found to be roughly proportional to the molecular
weight of NS2, indicating that the solvent-induced unfolding transition of this protein indeed follows a two-state mechanism (56, 57).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Solvent-induced unfolding of NS2. NS2
was incubated for 5 min in 150 mM NaCl, 20 mM
HEPES, 1 mM EDTA, 0-6 M guanidinium chloride,
pH 7.5, or in 150 mM NaCl, 20 mM borate/boric
acid, 0-6 M guanidinium chloride, pH 7.5, respectively.
, NS2 unfolding monitored by circular dichroism spectroscopy at 220 nm. , NS2 unfolding monitored by fluorescence emission at 342 nm.
|
|
Protease Mapping Reveals a Bipartite Structure of NS2--
To gain
further insight into the structure of NS2, protein digestion
experiments using trypsin and V8 protease were carried out. Limited
proteolysis of a folded protein is thought to be dominated by the
stereochemistry and the dynamics of the protein conformation, and has
been used successfully to probe the structure of native as well as
partly folded proteins (58). Both trypsin and V8 protease are highly
specific and possess a large number of theoretical cut sites throughout
the primary sequence of NS2, making them suitable probes to study the
structure of this protein. When NS2 was digested using a range of
trypsin:NS2 ratios, one major digestion fragment of about 6 kDa was
observed by SDS-PAGE. In addition, a minor band of slightly smaller
size was obtained. Similarly, if NS2 was digested using V8 protease,
only one digestion fragment was observed that migrated with an apparent
molecular weight of 6,000-7,000 on SDS-PAGE (Fig.
7). The major protease cut sites of NS2
were mapped to residues Glu-47 and Arg-51 by N terminus
sequencing of the V8 digestion fragment and the major trypsin digestion
fragment, respectively. In addition, N terminus sequencing of the minor
trypsin digestion fragment revealed a second, less assessable trypsin
cleavage site at position Arg-61. A hexahistidine-tagged version of
NS22 showed the same cut sites as conventionally purified
NS2, and was probed for retention of the C-terminal hexahistidine tag
by Western blot. All fragments were found to contain hexahistidine tags
indicating that they retained the C terminus of the full-length protein
(data not shown). The most N-terminal digestion sites that were fully
protected in the NS2 fragments were Glu-63 and Lys-64, while Glu-112
and Arg-114 were the most C-terminal digestion sites that were not
assessable to their proteases. These results indicate that residues
63-115 of NS2 form the minimal core of the protease-resistant region
of NS2. No fragments corresponding to the N terminus of NS2 were
observed, even if very low quantities of proteases were employed and
very short digestion times were used. As limited digestion of globular
proteins typically yields nicked species that retain their overall fold
under nondenaturing conditions (58), these results suggests a highly
exposed and flexible structure for the N terminus of NS2. The C
terminus of the protein, in contrary, assumes a comparatively
protease-resistant conformation.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 7.
Protease mapping of NS2. Trypsin
digestions of NS2 were carried out at 37 °C using 0.4 units
of immobilized trypsin/mg NS2 in 150 mM NaCl, 50 mM HEPES, pH 8.0. V8 protease digestions of NS2 were
performed using 4.0 units of immobilized V8 protease/mg of NS2 in 150 mM NaCl, 20 mM HEPES, pH 7.8. Reactions were
stopped by filtration through 0.2-µm filtration units, and the
samples were analyzed by 13.5% SDS-PAGE and staining with Coomassie
Brilliant Blue.
|
|
 |
DISCUSSION |
In this study we have characterized the structure of isolated
influenza virus protein NS2 in solution using a combination of
biochemical and biophysical techniques. For this purpose, NS2 was
expressed in E. coli and purified to homogeneity from the soluble fraction of the cell lysate using conventional techniques. The
recombinant protein was capable of interacting with influenza virus
protein M1, as found for both the viral protein, and for NS2 produced
in infected cells (26, 27). In addition, recombinant NS2 was quite
soluble and stable in a variety of buffers for extended periods of
time, and did not exhibit the extensive aggregation and precipitation
usually observed for misfolded proteins. While one study reported
partial phosphorylation of NS2 produced in infected cells (59), another
group found no phosphorylation of NS2 in their system (20). The
structure of recombinant NS2 was therefore considered representative of
at least one form of NS2 present in vivo.
If the structure and aggregation state of NS2 was probed by analytical
gel filtration and analytical ultracentrifugation, isolated NS2 was
found to exist as a globular, non-interacting monomer. While far-UV CD
and FT-IR spectroscopy detected the presence of a significant amount of
secondary structure in NS2, near-UV CD and fluorescence spectroscopy
revealed that the aromatic residues of the protein were highly
assessable to the solvent, and did not undergo strong interactions with
neighboring groups. Furthermore, isolated NS2 strongly interacted with
the hydrophobic dye ANS suggesting that hydrophobic clusters within the
structure of the protein were assessable to the solvent as well (51).
While GdmCl-induced unfolding of NS2 was characterized by a highly
cooperative transition, no distinct heat absorption peak was associated
with temperature-induced denaturation of the protein as determined by
differential scanning calorimetry. Taken together, these results
suggest the presence of a fluid-like hydrophobic core in NS2 that lacks
rigid packing interactions. Nonetheless, the nonlinear transition
observed if thermal unfolding of the protein was monitored by far-UV CD
spectroscopy may point to the presence of some areas of more tightly
packed structure within NS2, whose enthalpy change may be too small to be detected.
The flexibility observed in NS2 was intriguing, as with a length of 121 residues the protein is by far large enough to fold independently. The
unusual set of characteristics found in the structure of NS2
(compactness, presence of a pronounced secondary structure, but absence
of a tightly packed tertiary structure) are attributes typically
connected with the molten globule state of proteins (52, 60). While
this state had first been identified as a kinetic intermediate in
protein folding, since then it has also been found under equilibrium
conditions (usually at acidic pH or in the presence of alcohol) in a
number of proteins. While the "classical" molten globule model does
not contain strong tertiary interactions, it is thought to retain a
native-like tertiary fold and a loosely packed hydrophobic core (52,
60). Furthermore, a relatively tightly packed subdomain has since been
found in the molten globule state of a number of proteins that has been proposed to be responsible for the two-state transition observed during
solvent-induced unfolding of the molten globule state (61-65). Protease mapping of NS2 suggests that the flexibility observed in this
protein is not distributed equally over the whole molecule as well, but
that its N terminus assumes a significantly more flexible and solvent
exposed conformation than its C terminus, which adopts a comparatively
protease-resistant structure. Interestingly, both tryptophan residues
of NS2 are located within this C-terminal domain and both Trp-65 and
Trp-78 are surrounded by protease cut sites that appear inaccessible to
their the proteases (Glu-63, Lys-64, Arg-66, Glu-67, Glu-74, Glu-75,
Arg-77, Glu-81, and Glu-82). Nonetheless, the tertiary structure of NS2
in the vicinity of these aromatic groups was found to be only loosely
packed by near-UV CD and tryptophan fluorescence spectroscopy,
indicating that the C terminus of NS2, while more structured than its N
terminus, does not represent a rigidly packed domain as well. In
conclusion, the structure of NS2 appears to assume all the
characteristics typically described for the molten globule state. But
in contrast to most proteins that are known to be capable of assuming
this conformational state, NS2 adopts its molten globule-like structure under near physiological conditions and retains at least partial activity in this conformation. These observations suggest that the
plasticity observed in NS2 may be connected to its function in
vivo.
In recent years, molten globule-like conformations as found in NS2, as
well as partly folded and even unfolded states of proteins have been
found to exert important functions in vivo (66, 67). The
flexibility and adaptability of these structures are thought to mediate
the transport of proteins through membranes (68, 69), to facilitate the
specific recognition of RNA by proteins (70, 71), and to play a role in
ribosome assembly (72). Protein-protein interactions in particular
often seem to be mediated by disordered states of proteins. During
macromolecular assembly, plastic states are known to allow the
formation of extremely intimate interactions, which could not be formed
by the assembly of rigid structures (73). Furthermore, binding-induced
structure formation of highly flexible proteins has also been shown to
direct the assembly of multiprotein complexes (67, 74), and to allow precise regulation of binding events by phosphorylation or interaction with auxiliary factors (75-77). In addition, protein plasticity is
thought to a play key role in the ability of proteins such as
p21Waf1/Cip1/Sdi1 to interact with multiple ligands
(78).
The HIV-1 Rev-like NES of NS2 is located in its highly flexible
N-terminal region (18, 19, 23). In contrast to most proteins
investigated, the interaction of both NS2 and HIV-1 Rev with the
nuclear export receptor Crm1 is independent of the integrity of the NES
(19, 22, 23, 79, 80), indicating that regions surrounding the NES
itself may be involved in the optimal recognition of transport
substrates by Crm1. While the nuclear export domains of many proteins
assume a stable conformation in the absence of the nuclear export
machinery, others, like the effector domain of NS2 do not (21, 81-87).
These observations indicate that protein plasticity may play a role in
the assembly of the nuclear export complex and in the recognition of
cargo proteins by the nuclear export machinery.
Interestingly, if influenza virus-infected cells were exposed to the
cytotoxin leptomycin B, export of the proposed cargo of NS2, the vRNPs,
was efficiently inhibited. But even so the binding of Rev-like NESs to
Crm1 is thought to be inhibited by leptomycin B, the cellular
localization of NS2 was not or only slightly affected (12, 49, 88).
Similar results have also been reported if influenza virus-infected
cells were treated with U0126, an inhibitor of Raf signaling. Under
these conditions, the nuclear export of vRNPs was strongly inhibited,
but only moderate nuclear accumulation of NS2 was observed, even so RNA
export by a NS2-RevRBD fusion protein was abrogated (20). To explain
these contradictory results, Watanabe et al. (88) have
proposed that NS2 assumes two different forms in infected cells, one
which is associated transiently with the vRNPs and whose export is
leptomycin B-sensitive, and one which is not associated with the vRNPs,
and which is exported by a different, leptomycin B-insensitive export pathway. Our results show that the structure of NS2 is characterized by
a high degree of plasticity, indicating that NS2 may indeed exist in
multiple conformations in vivo.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Hughes for providing the NS2
cDNA, and Drs. C. Brouillette, D. D. Muccio, and H. C. Cheung for use of their equipment. We are grateful to T. Bogart, B. Pybus, and Drs. I. Protassevitch, P. Jackson, and J. Xing for technical
assistance and helpful discussions. We thank Drs. P. Prevelige and
J. B. Finley for a critical reading of this manuscript.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 205-934-4259;
Fax: 205-934-0480; E-mail: ming@cmc.uab.edu.
Published, JBC Papers in Press, December 20, 2001, DOI 10.1074/jbc.M109045200
2
B. S. Lommer, J. F. Kearney, and M. Luo, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
NP, nucleoprotein;
NS2, nonstructural protein 2 (also referred to as NEP, nuclear export protein);
Ran, Ras-related nuclear protein;
M1, matrix protein;
vRNP, viral ribonucleoprotein complex;
Crm1, chromosome maintenance protein
1;
Rev, regulator of expression of virion proteins;
NES, nuclear export
signal;
HIV, human immunodeficiency virus;
GdmCl, guanidinium chloride;
FT-IR spectroscopy, Fourier Transform-infrared spectroscopy;
ANS, 4,4-dianilino-1,1-binaphthyl-5,5-disulphonic acid;
RevRBD, RNA binding
domain of Rev.
 |
REFERENCES |
| 1.
|
Komeili, A.,
and O'Shea, E. K.
(2000)
Curr. Opin. Cell Biol.
12,
355-360[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Talcott, B.,
and Moore, M. S.
(1999)
Trends Cell Biol.
9,
312-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Moore, M. S.
(1998)
J. Biol. Chem.
273,
22857-22860[Free Full Text]
|
| 4.
|
Whittaker, G.,
Bui, M.,
and Helenius, A.
(1996)
Trends Cell Biol.
6,
67-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Whittaker, G. R.,
and Helenius, A.
(1998)
Virology
246,
1-23[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Murti, K. G.,
Brown, P. S.,
Bean, W. J., Jr.,
and Webster, R. G.
(1992)
Virology
186,
294-299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Baudin, F.,
Bach, C.,
Cusack, S.,
and Ruigrok, R. W.
(1994)
EMBO J.
13,
3158-3165[Medline]
[Order article via Infotrieve]
|
| 8.
|
Whittaker, G.,
Bui, M.,
and Helenius, A.
(1996)
J. Virol.
40,
2743-2756
|
| 9.
|
O'Neill, R. E.,
Jaskunas, R.,
Blobel, G.,
Palese, P.,
and Moroianu, J.
(1995)
J. Biol. Chem.
270,
22701-22704[Abstract/Free Full Text]
|
| 10.
|
O'Neill, R. E.,
and Palese, P.
(1995)
Virology
206,
116-125[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Wang, P.,
Palese, P.,
and O'Neill, R. E.
(1997)
J. Virol.
71,
1850-1856[Abstract]
|
| 12.
|
Elton, D.,
Simpson-Holley, M.,
Archer, K.,
Medcalf, L.,
Hallam, R.,
McCauley, J.,
and Digard, P.
(2000)
J. Virol.
75,
408-419[Abstract/Free Full Text]
|
| 13.
|
Ye, J.,
Robinson, D.,
and Wagner, R. R.
(1995)
J. Virol.
69,
1964-1970[Abstract]
|
| 14.
|
Martin, K.,
and Helenius, A.
(1991)
Cell
67,
117-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Bui, M.,
Willis, E. G.,
Helenius, A.,
and Whittaker, G. R.
(2000)
J. Virol.
74,
1781-1786[Abstract/Free Full Text]
|
| 16.
|
Rey, O.,
and Nayak, D. P.
(1992)
J. Virol.
66,
5815-5824[Abstract/Free Full Text]
|
| 17.
|
Zhirnov, O. P.,
and Klenk, H.-D.
(1997)
Virology
235,
302-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
O'Neill, R. E.,
Talon, J.,
and Palese, P.
(1998)
EMBO J.
17,
288-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Paragas, J.,
Talon, J.,
O'Neill, R. E.,
Anderson, D. K.,
Garcia-Sastre, A.,
and Palese, P.
(2001)
J. Virol.
75,
7375-7383[Abstract/Free Full Text]
|
| 20.
|
Pleschka, S.,
Wolff, T.,
Ehrhardt, C.,
Hobom, G.,
Planz, O.,
Rapp, U. R.,
and Ludwig, S.
(2001)
Nat. Cell Biol.
3,
301-305[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Fischer, U.,
Huber, J.,
Boelens, W. C.,
Mattaj, I. W.,
and Luhrmann, R.
(1995)
Cell
82,
475-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Askjaer, P.,
Jenson, T. H.,
Nilsson, J.,
Englmeier, L.,
and Kjems, J.
(1998)
J. Biol. Chem.
273,
33414-33422[Abstract/Free Full Text]
|
| 23.
|
Neumann, G.,
Hughes, M. T.,
and Kawaoka, Y.
(2000)
EMBO J.
19,
6751-6758[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Mena, I.,
Vivo, A.,
Perez, E.,
and Portela, A.
(1996)
J. Virol.
70,
5016-5024[Abstract/Free Full Text]
|
| 25.
|
Gomez-Puertas, P.,
Mena, I.,
Castillo, M.,
Vivo, A.,
Perez-Pastrana, E.,
and Portela, A.
(1999)
J. Gen. Virol.
80,
1635-1645[Abstract]
|
| 26.
|
Yasuda, J.,
Nakada, S.,
Kato, A.,
Toyoda, T.,
and Ishihama, A.
(1993)
Virology
196,
249-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Ward, A. C.,
Castelli, L. A.,
Lucantoni, A. C.,
White, J. F.,
Azad, A. A.,
and Macreadie, I. G.
(1995)
Arch. Virol.
140,
2067-2073[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Fornerod, M.,
Ohno, M.,
Yoshida, M.,
and Mattaj, I. W.
(1997)
Cell
90,
967-970[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Devereux, J.,
Haeberli, P.,
and Smithies, O.
(1984)
Nucleic Acids Res.
12,
387-395
|
| 30.
|
Sha, B.,
and Luo, M.
(1997)
Acta Cryst. Sect. D
53,
458-460[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
AB, P. B.
(1996)
UNICORN version 2 (30) User Manual 18-1121-98
, Edition AA
, Pharmacia Biotech AB, Uppsala, Sweden
|
| 32.
|
Siegel, L. M.,
and Monty, K. J.
(1966)
Biochim. Biophys. Acta
112,
346-362[Medline]
[Order article via Infotrieve]
|
| 33.
|
Lakowicz, J. R.
(1983)
Principles of Fluorescence Spectroscopy
, Plenum Press, New York
|
| 34.
|
Eftink, M. R.,
and Ghiron, C. A.
(1976)
Biochemistry
15,
672-680[CrossRef][Medline]
|